347460 <common-name>(4z)-2-[2-(9-bromoindolo[3,2-b]quinoxalin-6-yl)acetyl]-4-[1-(4-chlorophenyl)ethylidene]-5-methylpyrazol-3-one</common-name> <description>(4z)-2-[2-(9-bromoindolo[3,2-b]quinoxalin-6-yl)acetyl]-4-[1-(4-chlorophenyl)ethylidene]-5-methylpyrazol-3-one is a chemical compound with the formula C28H19BrClN5O2. With an average molecular weight of 572.80 g/mol, (4z)-2-[2-(9-bromoindolo[3,2-b]quinoxalin-6-yl)acetyl]-4-[1-(4-chlorophenyl)ethylidene]-5-methylpyrazol-3-one is a heavy molecule.</description> <cas>119457-35-1</cas> <pubchem-id>3088830</pubchem-id> <chemical-formula>C28H19BrClN5O2</chemical-formula> <weight>572.8</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:13:20Z</created-at> <updated-at type="dateTime">2026-08-31T11:13:20Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=NN(C(=O)C1=C(C)C2=CC=C(C=C2)Cl)C(=O)CN3C4=C(C=C(C=C4)Br)C5=NC6=CC=CC=C6N=C53</moldb-smiles> <moldb-formula>C28H19BrClN5O2</moldb-formula> <moldb-inchi>InChI=1S/C28H19BrClN5O2/c1-15(17-7-10-19(30)11-8-17)25-16(2)33-35(28(25)37)24(36)14-34-23-12-9-18(29)13-20(23)26-27(34)32-22-6-4-3-5-21(22)31-26/h3-13H,14H2,1-2H3/b25-15-</moldb-inchi> <moldb-inchikey>FEXJQYUANQLGNS-MYYYXRDXSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">571.04107</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.5</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343353</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(4z)-2-[2-(9-bromoindolo[3,2-b]quinoxalin-6-yl)acetyl]-4-[1-(4-chlorophenyl)ethylidene]-5-methylpyrazol-3-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Diazanaphthalenes</klass> <subklass>Benzodiazines</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0297802</sync-id> <structure-inchikey>FEXJQYUANQLGNS-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>42000000090000000000000000000000000000000108000004000400000004000002000000000000000200000040000000000000000080000000000000000000040000000040000000000402000000000000000000080000000020800000021008000000000000011000100040000014000000000000000004040000000004002020080400000000000000400000080010000000011000000000000000000800000000004000208400000000000400000000000000000000000000000000000000000000000010000000000001000c000002820000200000000000000800000000001000040000000000400000000400000000000000004000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKgAAAIABBgBgAAAAAQMGACgAAAAD BAcAKAAAAAMDBwAoAAAAAwMGACgAAAADBAgAKAAAAAMCBgAoAAAAAwQGACgA AAADBAYAYAAAAAEDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAREAIAAAAAEGACgAAAADBAgAKAAAAAMCBgBg AAAAAgIHQCgAAAADAwZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDASMAIAAAAAEGQCgAAAADBAdAKAAAAAMDBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgA AAADBAdAKAAAAAMDBkAoAAAAAwQLAAEAAQIoAgIDIAMEIAQFKAIEBiAGBygC BwgABwkgCQpoDAoLaAwLDGgMDA1oDA0OaAwMDwADECAQESgCEBIAEhMAExRo DBQVaAwVFmgMFhdoDBcYaAwYGWgMFxoAFRtoDBscaAwcHWgMHR5oDB4faAwf IGgMICFoDCEiaAwiI2gMIyRoDAYBIA4JaAwkE2gMGRRoDCQbaAwiHWgMQgYA AAAFAQIDBAYGCgsMDQ4JBhYXGBkUFQYcHSIjJBsGHh8gISIdBRMUFRskFwQA AAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:01Z</structure-indexed-at> </compound>